U.S. Physical Therapy Reports Mixed Q1 2026 Results Amid Growth Initiatives
Event summary
- U.S. Physical Therapy reported Q1 2026 revenue of $198.3 million, up 7.9% YoY, but net income fell to $5.0 million from $9.9 million due to a $2.0 million loss on contingent earn-out consideration.
- Patient visits increased by 6.9% YoY to 1,543,144, with physical therapy net revenue rising 7.2% to $167.7 million.
- IIP revenue grew 11.8% YoY to $30.6 million, with margins improving to 20.4% from 18.6%.
- The company added 15 and closed 12 clinics, ending Q1 with 783 clinics.
- Management reaffirmed full-year 2026 adjusted EBITDA guidance of $102.0 million to $106.0 million.
The big picture
U.S. Physical Therapy's Q1 2026 results reflect a strategic focus on expanding its hospital alliances and enhancing operational efficiency through technology. The company's growth in patient visits and IIP revenue underscores its position in the outpatient physical therapy market, but integration risks and margin pressures remain key watchpoints. The reaffirmed full-year guidance suggests confidence in its strategic initiatives, despite near-term earnings volatility.
What we're watching
- Integration Challenges
- The pace at which U.S. Physical Therapy can integrate its recent hospital alliances and acquisitions will determine the timing and magnitude of expected EBITDA contributions.
- Operational Efficiency
- Whether the company's initiatives to virtualize front-desk operations and implement ambient-listening technology will sustainably improve margins and patient outcomes.
- Financial Flexibility
- How the expanded $450 million credit facility will be utilized to support growth in physical therapy, industrial injury prevention, and hospital alliance expansions.
Related topics